Cited by 109

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Chemoattractant-Stimulated Rac Activation in Wild-Type and Rac2-Deficient Murine Neutrophils: Preferential Activation of Rac2 and Rac2 Gene Dosage Effect on Neutrophil Functions

Li, Shijun, Yamauchi, Akira, Marchal, Christophe C, Molitoris, Jason K, Quilliam, Lawrence A, Dinauer, Mary C·2002·The Journal of Immunology

Abstract

The hemopoietic-specific Rho family GTPase Rac2 shares 92% amino acid identity with ubiquitously expressed Rac1. Neutrophils from rac2−/− mice have multiple defects, including chemoattractant-stimulated NADPH oxidase activity and chemotaxis, which may result from an overall reduction in cellular Rac or mechanisms that discriminate Rac1 and Rac2. We show that murine neutrophils have similar amounts of Rac1 and Rac2, unlike human neutrophils, which express predominantly Rac2. An affinity precipitation assay for Rac-GTP showed that although FMLP-induced activation of both isoforms in wild-type neutrophils, ≈4-fold more Rac2-GTP was detected than Rac1-GTP. Wild-type and Rac2-deficient neutrophils have similar levels of total Rac1. FMLP-induced Rac1-GTP in rac2−/− neutrophils was ≈3-fold greater than in wild-type cells, which have similar levels of total Rac1, yet FMLP-stimulated F-actin, chemotaxis, and superoxide production are markedly impaired in rac2−/− neutrophils. Heterozygous rac2+/− neutrophils, which had intermediate levels of total and FMLP-induced activated Rac2, exhibited intermediate functional responses to FMLP, suggesting that Rac2 was rate limiting for these functions. Thus, phenotypic defects in FMLP-stimulated Rac2-deficient neutrophils appear to reflect distinct activation and signaling profiles of Rac 1 and Rac2, rather than a reduction in the total cellular level of Rac.

Overview

Integrity signals

Registry

Crossref · 10.4049/jimmunol.169.9.5043

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 5 references

Research works printed but not linked: 67

  1. 1998, Science, 509
  2. 2000, EMBO J., 2393
  3. 2000, Biochem. J., 241
  4. 1997, Genes Dev., 2295
  5. 2001, Science, 1299
  6. 1995, Blood, 1649
  7. 1991, Nature, 668
  8. 1991, Science, 1512
  9. 1996, J. Biol. Chem., 83
  10. 1997, J. Biol. Chem., 18834
  11. 1994, Science, 531
  12. 1999, J. Biol. Chem., 25051
  13. 1996, Biochemistry, 15683
  14. 1994, J. Biol. Chem., 30749
  15. 2001, Nat. Immunol., 211
  16. 2000, J. Leukocyte Biol., 593
  17. 1998, Science, 1717
  18. 1997, J. Exp. Med., 1487
  19. 2000, J. Cell Biol., 785
  20. 1989, J. Biol. Chem., 16378
  21. 1997, J. Biol. Chem., 20384
  22. 1991, Oncogene, 863
  23. 1990, Oncogene, 769
  24. 2001, J. Immunol., 1223
  25. 2001, Proc. Natl. Acad. Sci. USA, 5614
  26. 2000, Immunity, 557
  27. 1999, Immunity, 183
  28. 2000, Proc. Natl. Acad. Sci. USA, 4654
  29. 2000, Blood, 1646
  30. 1999, J. Biol. Chem., 2279
  31. 1993, Proc. Natl. Acad. Sci. USA, 9832
  32. 1999, J. Immunol. Methods, 3
  33. 1997, Blood, 41
  34. 1999, Trends Pharmacol. Sci., 365
  35. 2001, J. Biol. Chem., 15929
  36. 1999, Blood, 1121
  37. 1999, J. Biol. Chem., 13198
  38. 1999, J. Biol. Chem., 18055
  39. 2002, J. Leukocyte Biol., 115
  40. 1996, J. Biol. Chem., 25204
  41. 1995, J. Biol. Chem., 19969
  42. 1993, Mol. Biol. Cell, 261
  43. 2001, Oncogene, 8057
  44. 2000, Nature, 682
  45. 2001, J. Cell Biol., 111
  46. 1999, Cell, 69
  47. 1998, J. Biol. Chem., 1782
  48. 2000, J. Biol. Chem., 32260
  49. 1998, Oncogene, 1417
  50. 1998, J. Biol. Chem., 24052
  51. 2002, J. Biol. Chem., 272
  52. 1999, Nat. Cell Biol., 98
  53. 2002, Nat. Cell Biol., 343
  54. 2002, Cancer Res., 1241
  55. 2001, Nat. Cell Biol., 368
  56. 2000, Oncogene, 4582
  57. 1998, J. Biol. Chem., 21512
  58. 1995, EMBO J., 5297
  59. 1996, J. Biol. Chem., 19794
  60. 1998, J. Biol. Chem., 17991
  61. 1998, Biochemistry, 7147
  62. 1995, J. Leukocyte Biol., 108
  63. 1998, Science, 558
  64. 1998, Science, 560
  65. 2001, Oncogene, 6372
  66. 2002, Cell, 809
  67. 2000, Science, 1046

Cited by

Metadata

Authors
Li, S., Yamauchi, A., Marchal, C. C., Molitoris, J. K., Quilliam, L. A., & Dinauer, M. C.
Affiliations
  • Herman B Wells Center for Pediatric Research and Departments of Pediatrics (Hematology/Oncology), Microbiology/Immunology, and Medical and Molecular Genetics, Biochemistry and Molecular Biology , Indianapolis, IN 46202
  • Walther Oncology Center and Walther Cancer Institute , Indianapolis, IN 46202
  • James Whitcomb Riley Hospital for Children, Indiana University Medical School , Indianapolis, IN 46202
Venue
The Journal of Immunology
Published
2002-11-01
Volume
169
Issue
9
Pages
5043-5051
ISSN
  • 0022-1767
  • 1550-6606
Cited by
109
References
5
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review